Representing ConTIPI Medical Ltd. on Raising $40,000,000 of Structured Capital

Congratulations to our client ConTIPI Medical Ltd. on raising $40,000,000 of structured capital in a complex cross-border secured lending transaction together with the execution of a joint commercialization agreement with the multinational Indegene group.

ConTIPI was advised in both transactions by Adv. Gershon Shalom-Winter, together with Adv. Karin Abramovich and Lior Hassine. Adv. Itay Hass provided special assistance in connection with the securitization aspects of the transaction.

ConTIPI is an innovator in the field of providing non-surgical and disposable solutions for woman with various pelvic floor disfunctions and the proceeds of the transaction will be used to bring to market ConTIPI’s ProVate device, intended to manage Pelvic Organ Prolapse (POP) in women.

The joint commercialization agreement with Indegene includes several services across the commercialization process in the United States.